An observational study in Narcolepsy, sponsored by Jazz Pharmaceuticals. Status unknown at 25 sites in United States. Open to participants aged Up to 17 Years. Per ClinicalTrials.gov, last updated 2024-08-15.
Sponsored by Jazz Pharmaceuticals · Observational
CATNAP is a patient registry designed to improve the understanding of the natural history of narcolepsy in pediatric patients. Descriptive statistics on disease characteristics will be performed.
The study has 16 active clinical sites and a virtual site that widens participation to anywhere in the United States. For more information about the study or to access the Online Patient Enrollment System, visit the CATNAP website: https://catnap.healthie.net/welcome or email catnap@pulseinfoframe.com. The Online Patient Enrollment System, CATNAP website, can also be found in the references section.
152 studies on the registry are indexed under Narcolepsy; 32 are open to participants now.
This study's planned enrollment of 500 is above the median of 120 across 36 observational studies indexed under Narcolepsy.
Browse Narcolepsy studies →Jazz Pharmaceuticals is the lead sponsor of 173 studies on the registry; 19 are open to participants now.
Of its 42 completed or terminated interventional studies of FDA-regulated products, 31 (74%) have results posted.
Counted across the registry records on this site, refreshed daily.
Any child or adolescent with a physician-confirmed diagnosis of narcolepsy
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Improve Understanding of Natural History of Pediatric Narcolepsy
Time frame: Up to 4 years
Characterize the Presentation, Identification, and Diagnosis of Narcolepsy in Pediatric Participants
Time frame: Up to 4 years
Understand Treatment Practices and Outcomes Captured by Treatment Regimen and Rational for Changes
Time frame: Up to 4 years
Improvements in Quality of Life (QoL) as Measured by Epworth Sleepiness Scale for Children and Adolescents (ESS-CHAD) Questionnaire
Time frame: Up to 4 years
QoL - Pediatric Quality of Life Inventory (PedsQL)
Time frame: Up to 4 years
Change in frequency of child ehavioral problems utilizing the Child Behavior Checklist (CBCL)
Time frame: Up to 4 years
Patient Reported Outcomes Measurement Information System (PROMIS) Peer Relationship-Parent Proxy Short Form v2.0
Time frame: Up to 4 years
Caregiver Work Limitations Questionnaire (C-WLQ)
Time frame: Up to 4 years
Work Productivity and Activity Impairment (WPAI)
Time frame: Up to 4 years
Change in Caregiver Well-being Measured by the Caregiver Well-Being Scale (Shortened)
Time frame: Up to 4 years
Change in Level of Social Support using the Social Support Survey Instrument
Time frame: Up to 4 years
Change in Pittsburgh Sleep Quality index (PSQI) scores
Time frame: Up to 4 years
Started Oct 2020 (actual). Primary completion is estimated for Oct 2024, 47 months after the start.
Of 18 observational studies under Narcolepsy, half reached primary completion within 61 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 73. This study's planned 47 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.